1. Home
  2. IMMP vs THCH Comparison

IMMP vs THCH Comparison

Compare IMMP & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immutep Limited

IMMP

Immutep Limited

N/A

Current Price

$3.60

Market Cap

31.5M

Sector

Health Care

ML Signal

N/A

Logo TH International Limited Ordinary shares

THCH

TH International Limited Ordinary shares

N/A

Current Price

$1.00

Market Cap

37.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMP
THCH
Founded
1987
2018
Country
Australia
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
37.2M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
IMMP
THCH
Price
$3.60
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 303.6K
6.2K
Earning Date
09-01-2026
08-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$1.09
52 Week High
$5.36
$3.25

Technical Indicators

Market Signals
Indicator
IMMP
THCH
Relative Strength Index (RSI) 67.55 32.05
Support Level $2.65 N/A
Resistance Level $5.36 $2.27
Average True Range (ATR) 0.22 0.09
MACD 0.11 -0.02
Stochastic Oscillator 64.73 0.00

Price Performance

Historical Comparison
IMMP
THCH

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

About THCH TH International Limited Ordinary shares

TH International Ltd is the exclusive master franchisee in China for Tim Hortons, a world-wide coffee and bakery shop brand. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under a single reportable segment, Tim Hortons. The company's revenue is derived from sales of food, beverages, and packaged products by company-owned and operated stores, franchise fees, and revenue from other franchise support activities. Its geographic revenue is derived from operations in the PRC.

Share on Social Networks: